Basco, Ezekiel .
HRN: 22-71-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/20/2024
10/30/2024
IIV
100
Q8h
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes